On May 24, 2024, the HOSPITALAR exhibition, a significant event in the global healthcare industry, concluded successfully after four days of vibrant engagement. The event attracted over 1,200 medical enterprises and more than 90,000 professionals. As one of South America’s largest comprehensive healthcare exhibitions, HOSPITALAR showcased a wide range of products, including medical equipment, diagnostic devices, medical consumables, laboratory technology, and electronic health solutions. It played a crucial role in connecting various sectors of the healthcare industry and promoting trade cooperation. 

JIEZLAB presented two self-developed devices: Biochemistry Analyzer and Immunoassay Analyzer, along with microfluidic kits. Products based on microfluidic technology garnered significant interest from South American clients due to their microliter sample, user-friendliness, and built-in quality control.

The two analyzers have internal centrifuge, meanwhile, integrate seamlessly with spectrometry and time-resolved fluorescence approaches. The sample separation, plasma quantitation, dilution, mixing, and reaction are all accomplished on a microchip. These designs enhance detection sensitivity and specificity while maintaining Sample in, Results out characteristic of POCT. Compact in design, easy to operate, adaptable for flexible throughput, and applicable across a wide range of tests, the instruments meet the needs of healthcare facilities in Brazil. 

Brazil, South America’s largest country with over 6,800 hospitals, has a relatively advanced healthcare system, but it confronts issues due to uneven resource distribution and dispersed healthcare facilities, forcing many small clinics to rely on central labs for sample testings. Microfluidic-based POCT products can fulfill the self-testing needs of these clinics. Timely results help clinics efficient patients' management. 

During the exhibition, the products are highlighted for their ease of use, microliter sample, and comprehensive testing capabilities. 50μL whole blood is used in testing because of the internal centrifuge in the analyzers and the microfluidic design of plasma quantitation in test kits. This will significantly reduce operational steps, making the products suitable for use in ICUs and Emergency Departments. The reagent kits, which can be stored and transported at 2-25°C, are also ideal for distributor logistics within Brazil.

Brazil is one of the countries with a high prevalence of chronic metabolic diseases. The number of diabetes patients in Brazil continues to rise annually, with over 30% of them remaining undiagnosed and not regularly monitored. JIEZLAB’s Biochemistry Analyzer can measure blood glucose, lipids, HbA1c, the albumin-to-creatinine ratio (ACR), etc. All-in-One design makes this analyzer suitable for diabetes patients' management.

The two product series showcased by JIEZLAB address the Brazilian market’s demand for early and precise disease detection while meeting the urgent and ICU requirements for accurate, quantitative POCT products. Numerous distributors and physicians observed the testing processes of both analyzers during the exhibition, actively engaging with our technical staff to express their appreciation for the products’ user-friendly operation and sophisticated design. Several local distributors established further cooperation on-site, strengthening our overseas market channel development.

This exhibition marks a significant step of JIEZLAB in expanding internationally. In the second half of the year, we will present more feature products at the 4^th Russian Diagnostic Summit (RDS) in Russia and 2024 MEDICA in Düsseldorf. We cordially invite you to visit and collaborate with us; we look forward to seeing you there!